These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

28 related articles for article (PubMed ID: 6158722)

  • 1. Eye disease drug as a potential cure for COVID-19: one foot-in-the-door.
    Patel P
    Eye (Lond); 2023 Oct; 37(14):2844-2846. PubMed ID: 36813997
    [No Abstract]   [Full Text] [Related]  

  • 2. [Papain electrophoresis in treatment of eye diseases].
    Starkov GL; Abramova IN
    Oftalmol Zh; 1975; 30(6):450-3. PubMed ID: 1228526
    [No Abstract]   [Full Text] [Related]  

  • 3. [Rationale for using rheopolyglucin electrophoresis in eye diseases].
    Pil'ganchuk VV
    Vestn Oftalmol; 1987; 103(3):59-62. PubMed ID: 2442877
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effectiveness of novocaine diadynamophoresis in the treatment of postoperative pain after lung surgery].
    Sokolov SB; Korchagin AB; Leshchinskaia NP
    Vopr Kurortol Fizioter Lech Fiz Kult; 1976; (4):61-3. PubMed ID: 1014438
    [No Abstract]   [Full Text] [Related]  

  • 5. [Drug electrophoresis in the overall treatment of the eye lesions in endocrine diseases].
    Danilova AI
    Oftalmol Zh; 1980; 35(5):268-72. PubMed ID: 7422212
    [No Abstract]   [Full Text] [Related]  

  • 6. [Iontophoresis of calcium and adrenaline in treatment of inflammatory conditions of the eyes].
    Mika T; Szymankowa G; Lisowski Z; Merz M
    Klin Oczna; 1968; 38(3):497-502. PubMed ID: 5668389
    [No Abstract]   [Full Text] [Related]  

  • 7. [Drug diadynamophoresis in the overall treatment of eye diseases].
    Khriapchenkova MP; Ladniuk TA
    Oftalmol Zh; 1980; 35(5):275-8. PubMed ID: 6158722
    [No Abstract]   [Full Text] [Related]  

  • 8. Iontophoresis: a non-invasive ocular drug delivery.
    Eljarrat-Binstock E; Domb AJ
    J Control Release; 2006 Feb; 110(3):479-89. PubMed ID: 16343678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent progress in ocular drug delivery for posterior segment disease: emphasis on transscleral iontophoresis.
    Myles ME; Neumann DM; Hill JM
    Adv Drug Deliv Rev; 2005 Dec; 57(14):2063-79. PubMed ID: 16310884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Iontophoresis: past and future].
    Behar-Cohen F; El Aouni A; Le Rouic JF; Parel JM; Renard G; Chauvaud D
    J Fr Ophtalmol; 2001 Mar; 24(3):319-27. PubMed ID: 11285450
    [No Abstract]   [Full Text] [Related]  

  • 11. Ophthalmic drug delivery: development and regulatory considerations.
    Novack GD
    Clin Pharmacol Ther; 2009 May; 85(5):539-43. PubMed ID: 19225448
    [No Abstract]   [Full Text] [Related]  

  • 12. [The use of magnetic fields in ophthalmology].
    Skrinnik AV; Moiseeva NN
    Oftalmol Zh; 1990; (8):492-6. PubMed ID: 2095478
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.